Valuation: Celularity Inc.

Market Cap 19.87M 17.21M 16.08M 14.7M 27.7M 1.9B 28.13M 189M 74M 948M 74.63M 73M 3.16B P/E 2024
-0.79x
P/E 2025 -0.31x
Enterprise Value 88.41M 76.54M 71.54M 65.38M 123M 8.43B 125M 839M 329M 4.22B 332M 325M 14.05B EV / Sales 2024
2.12x
EV / Sales 2025 3.77x
Free-Float
62.82%
Yield 2024 *
-
Yield 2025 -
1 day-2.01%
1 week+4.00%
Current month+8.07%
1 month-7.27%
3 months-21.97%
6 months-45.94%
Current year-38.14%
1 week 0.68
Extreme 0.68
0.75
1 month 0.6
Extreme 0.601
0.84
Current year 0.56
Extreme 0.5601
1.51
1 year 0.56
Extreme 0.5601
4.31
3 years 0.56
Extreme 0.5601
7.97
5 years 0.56
Extreme 0.5601
131.86
10 years 0.56
Extreme 0.5601
134
Manager TitleAgeSince
Chief Executive Officer 66 01/01/2016
Director of Finance/CFO 67 27/02/2026
Compliance Officer 42 01/07/2021
Director TitleAgeSince
Chairman 66 01/01/2016
Director/Board Member 64 01/07/2017
Director/Board Member 73 03/06/2022
Date Insider Type Main position Quantity % Market Cap.
12/01/26 Free

Director

19,231 0.0667%
12/01/26 Free

Director

30,000 0.1040%
12/01/26 Free

Director

19,231 0.0667%
Change 5-day change 1-year change 3-year change Capi.($)
-2.01%+4.00%-78.81%-79.69% 19.87M
+3.02%+6.43%+43.53%+1.90% 80.69B
+0.84%+10.26%-0.15%+27.24% 51.22B
+0.27%+1.07%+20.95%+175.18% 49.58B
+2.87%+7.37%-47.57%-48.01% 45.5B
-0.39%+2.63%+58.51%-23.02% 30.6B
+0.82%+2.63%+55.06%+85.54% 24.64B
+1.08%+8.47%+128.98%-40.36% 23.88B
-1.80%+10.21%+6.23%+188.24% 21.59B
+14.10%+42.49%+5.21%+848.43% 17.09B
Average +1.88%+82.18%+19.19%+113.54% 34.48B
Weighted average by Cap. +1.93%+86.74%+25.60%+78.45%

Financials

2024 2025
Net sales 54.22M 46.94M 43.87M 40.1M 75.56M 5.17B 76.74M 514M 202M 2.59B 204M 199M 8.62B 26.55M 22.98M 21.48M 19.63M 37M 2.53B 37.58M 252M 98.85M 1.27B 99.69M 97.52M 4.22B
Net income -57.89M -50.12M -46.84M -42.81M -80.68M -5.52B -81.94M -549M -216M -2.76B -217M -213M -9.2B -91.72M -79.4M -74.21M -67.83M -128M -8.75B -130M -870M -341M -4.38B -344M -337M -14.57B
Net Debt 68.1M 58.95M 55.1M 50.36M 94.9M 6.49B 96.39M 646M 254M 3.25B 256M 250M 10.82B 68.54M 59.33M 55.46M 50.69M 95.52M 6.54B 97.01M 650M 255M 3.27B 257M 252M 10.89B
Logo Celularity Inc.
Celularity Inc. is a regenerative and cellular medicine company. The Company is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. Its IMPACT manufacturing platform is a fully integrated process designed to optimize the speed of the sourcing of placentas from full-term healthy informed consent donors through the use of proprietary processing methods, cell selection, product-specific chemistry, manufacturing and control (CMC), advanced cell manufacturing and cryopreservation. It also provides contract manufacturing and development services to third parties.
Employees
115
Date Price Change Volume
10/08/26 $0.6866 -2.01% 25,668
07/08/26 $0.7007 +2.59% 18,067
06/08/26 $0.6830 -6.97% 25,838
05/08/26 $0.7342 +4.38% 10,292
04/08/26 $0.7034 +6.54% 77,815

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CELU Stock